Increased granulocyte aggregation in vitro in diabetes mellitus

QJM: An International Journal of Medicine

Volumn 90, Issue 7, 1997, Pages 461-464

  Elhadd, T A ^a   Bancroft, A ^a   McLaren, M ^a   Newton, R W ^a   Belch, J J F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CELL AGGREGATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKOCYTE; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL;

EID: 0030762869     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/90.7.461     Document Type: Article

References (30)

1. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before age 31. Diabetolog 1978; 14:463-77.
2. Banga JD. lower exrtremity arterial disease in diabetes mellitus. Diab Rev Int 1994; Vol 3 (4):7-11.
3. Belch JJF. The role of white blood cell in arterial disease. Blood Coag Fibrinol 1990; 1:183-92
4. Kostis JB, Turkevich D, Sharp J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary angiography. Am J Cardiol 1984; 53:997-9.
5. Prentice RL, Szatrowski TP, Kato H, Mason MW. Leukocyte counts and cerebrovascular disease. J Chron Dis 1982; 35:703-14.
6. Belch JJF, Frings M, Voleske P, Sohngen W. Neutrophil count and amputation in critical limb ischaemia (Abstract). Crit limb Ischaem 1994; 13:6.
7. Shonfeld Y, Pinkhas J. Leukopenia and low incidence of myocardial infarction. N Eng J Med 1981; 304:1606
8. Fisher TC, Belch JJF, Barbanel JC, Fisher AC. Human whole blood granulocyte aggregation in vitro. Clin Sci 1989; 76:183-7.
9. Bridges AB, Fisher TC, Scott N, McLaren M, Belch JJF. Circadin rhythm of white blood cell aggregation and free radical status in healthy vounteers. Free Rad Res Comm 1992; 16(2):89-97.
10. Bridges AB, Scott N, McNiell T, Pringle TH, Belch JJF. Circadian variation of white blood cell aggregation and free radical indices in men with ischaemic heart disease. Eur Heart J 1992; 13:1632-6
11. Mehta J, Dinerman J, Mehta P, et al. Neutrophil function in ischaemic heart disease. Circulation 1989; 79:549-56.
12. Bridges AB, Hill A, Belch JJF. Cigarette smoking increases white blood cell aggregation in whole blood. J Roy Soc Med 1993; 86:139-40
13. Taylor JE, Bridges AB, Henderson IS, Stewart WK, Belch JJF. Whole blood granulocyte aggregation in vitro in dialysis-dependent patients. Blood Coag Fib 1991; 2:765-9
14. Schmid-Schonbein GW, Engler RL. Granulocytes as active participants in acute myocardial ischaemia and infarction. Am J Cardiovasc Pathol 1986; 1:15-30.
15. Davies SW, Ranjadayalan K, Wickens DC, et al. Lipid peroxidation associated with successful thrombolysis. Lancet 1990; 335:741-3.
16. Woodward B, Zaharia MM. Effect of some free radical scavengers on reperfusion-induced arryhtmia in the isolated rabbit heart. J Mol Cell Cardiol 1985; 17:485-93.
17. Jennings PE, Jones AF, Florkowski CM, Lunec J, Barnett AH. Increased diene conjugate in diabetic patients with microangiopathy. Diabet Med 1987; 4:452-6.
18. Stringer MD, Gorog PC, Freeman A, et al. Lipid peroxides and atherosclerosis. Br Med J 1989; 298:281-4.
19. Williams LT, Synderman R, Pike MC, Lefkowitz RJ. Specific receptor sites for chemotactic peptides on human polymorphonuclear leucocytes. Proc Natl Acad Sci USA 1977; 74:1204-8.
20. Abramson SB, Weissmann G. The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1989; 32:1-9.
21. Rieu P, Porteu F, Bessou G, Lesavre P, Halbwachs-Mecarelli L. Human neutrophils release their major membrane sialoprotein Leukosialin CD43 during cell activation. Euro J Immunol 1992; 22 (11):3021-6.
22. Simons SI, Chambers JD, Butcher EC, Sklar LA. Neutrophil aggregation is β2 integrin and L-selectin dependent in blood and isolated cells. J Immunol 1992; 149 (8):2765-71.
23. Wolff SP. The potential role of oxidative stress in diabetes and its complications: novel implication for theory and therapy. In: Crabbe MJC, editor. Diabetic Complications, Scientific and Clinical Aspects,1st edn. Edinburgh, Churchill Livingstone, 1987:167-220.
24. Wierusz-Wysocka B, Wysocki H, et al. Evidence of polymorhonuclear neutrophils (PMN) activation in patients with Insulin Dependent Diabetes melliytus. J Leuk Biol 1987; 42:519-23.
25. Candiloros H, Muller S, Ziegler, Donner M, Drouin P. Role of albumin glycation on the erythrocyte aggregation: An in vitro study. Diabet Med 1996; 13 (7):642-5.
26. Nishigaki I, Hagihara M, Tsunekawa H et al. Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem Med 1981; 25:373-8.
27. Sato Y, Hotta N, Sakamoto N, et al. Lipid peroxide level in plasma of diabetic patients. Biochem Med 1979; 21:104-7.
28. Vlassara H, Fuh H, Donnelly T, Cybulsky M. Advanced glycation endproducts promote adhesion molecules VCAM-1, ICAM-1 expression and atheroma formation in normal rabbits. Mol Med 1995; 1 (4):447-56.
29. Shah SV, Wallin ID, Eilen SD. Chemilumiscence and superoxide anion production by leukocytes from diabetic patients. J Clin Endocrin Metabol 1983; 57:402.
30. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978; 1:168-88, 252-63.